2024 Gastrointestinal Symposium

Friday, May 31, 2024

Conference starts in:

The Waterview - Port Jefferson, NY
1 Day Conference May 31st, 2024
6.00 AMA PRA Category 1 Credit Hours


The 2024 Stony Brook Cancer-Center GI Symposium is designed to effect changes in healthcare professionals' competence, performance, and ultimately, patient outcomes in the field of gastrointestinal oncology. 

Register Now

For pricing information, see pricing tab below.

Dates and Times

Start: 5/31/2024 8:00 AM
End: 5/31/2024 5:30 PM


  • Increase healthcare professional's competence in the latest advancements in gastrointestinal oncology, including treatment modalities and emerging therapies.
  • Demonstrate a measurable increase in their knowledge of the latest GI oncology treatment modalities as assessed through pre- and post-symposium knowledge assessments.  
  • Improve attendees' ability to make evidence-based clinical decisions for the diagnosis, treatment, and management of GI cancers. 
  • Display a measurable improvement in clinical decision-making skills, as assessed through case-based evaluations conducted during symposium.
  • Enhance healthcare professionals' competence in effectively collaborating with colleagues from various disciplines in the care of GI cancer patients.
  • Demonstrate a measurable increase in their participation in multidisciplinary discussions and care coordination, as observed through simulated scenarios or group exercises during the sessions. 
  • Develop competence in integrating palliative care principles into the treatment of GI cancer patients to improve their quality of life.
  • Engage in patient-centered communications and shared decision-making through observed interactions with standardized patients. 
  • Utilization of healthcare technologies, such as electronic health records and telemedicine.
  • Recognize addressing health care disparities in GI cancer care among different patient populations. 


  • Lionel D'Souza, MD
    • TBD
  • Julie Gemmill, DO
    • Updates on Current Gastrointestinal Clinical Trials
  • Georgios Georgakis, MD
    • Advanced Cancer Treatments
  • Jingfang Ju, PhD
    • Drug for Pancreatic Ductal Adenocarcinoma (PDAC)
  • Nancy Kemeny, MD
    • Metastatic Colorectal Cancer Hepatic Arterial Infusion (HAI) Therapy: The Past, Present and The Future - The Times are Changing
  • Grace Latorre, DO
    • Palliative Aspects
  • David Montrose, PhD
    • Microbiomes
  • Deborah Nagle, MD
    • New Colorectal Treatments
  • Kenneth Shroyer, MD
    • Keratin 17 Drives Biologic Aggression and Chemoresistance in Pancreatic Cancer
  • Alexander Stessin, MD
    • Rays of Hope
  • Nashaat Turkman, PhD
    • Theragnostic
  • Alisa Yurovsky, Doctorial Degree
    • Biomedical Informatics


  • Questions & Answers with Audience Participation
    • Dr. Lionel D'Souza, MD
    • Dr. Julie Gemmill, DO
    • Dr. Georgios Georgakis, MD
    • Dr. Jingfang Ju, PhD
    • Dr. Grace Latorre, DO
    • Dr. David Montrose, PhD
    • Dr. Deborah Nagle, MD
    • Dr. Kenneth Shroyer, MD
    • Dr. Alexander Stessin, MD
    • Dr. Nashaat Turkman, PhD
    • Dr. Alisa Yurovsky, Doctorial Degree


The Waterview
41 Fairway Drive
Port Jefferson, NY 11777


The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit(s) . Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Need help with this Conference?

Please contact the Conference coordinator listed below:

Donna Lovaglio
Department: OCME
Phone: (_63) 444-2094
Email: donna.lovaglio@stonybrookmedicine.edu

Give us a call
(631) 444-2094
Office of Continuing Medical Education
Renaissance School of Medicine at Stony Brook University
HSC, Level 2, Room 142
Stony Brook, New York 11794-8222